Recent Developments in Peptide-Based Nucleic Acid Delivery - sprookjes - yvandenbroek - TriplyDB

Recent Developments in Peptide-Based Nucleic Acid Delivery

Recent Developments in Peptide-Based Nucleic Acid Delivery

http://www.wikidata.org/entity/Q27487857

about

Mechanisms of nanoparticle-mediated siRNA transfection by melittin-derived peptides.Gene delivery from supercharged coiled-coil protein and cationic lipid hybrid complex.Serum stability and physicochemical characterization of a novel amphipathic peptide C6M1 for siRNA delivery.Manipulating miRNA Expression: A Novel Approach for Colon Cancer Prevention and Chemotherapy Peptides in cancer nanomedicine: drug carriers, targeting ligands and protease substrates.A role for peptides in overcoming endosomal entrapment in siRNA delivery - A focus on melittin Peptide-mediated cellular delivery of oligonucleotide-based therapeutics in vitro: quantitative evaluation of overall efficacy employing easy to handle reporter systems.Controlled delivery of antisense oligonucleotides: a brief review of current strategies.Plant antimicrobial peptides.Integrin targeted delivery of gene therapeutics Peptide vectors for gene delivery: from single peptides to multifunctional peptide nanocarriers.The role of hypoxia-induced miR-210 in cancer progression.Peptide-Based and Polypeptide-Based Gene Delivery Systems.Dendritic Guanidines as Efficient Analogues of Cell Penetrating Peptides Cell-Penetrating Peptides-Mechanisms of Cellular Uptake and Generation of Delivery Systems.Chimeric peptide-mediated siRNA transduction to inhibit HIV-1 infection.Computational design and experimental characterization of peptides intended for pH-dependent membrane insertion and pore formation Apoptosis-induced anticancer effect of transferrin-conjugated solid lipid nanoparticles of curcumin.Mutational mapping of UL130 of human cytomegalovirus defines peptide motifs within the C-terminal third as essential for endothelial cell infection.Improved Aptamers for the Diagnosis and Potential Treatment of HER2-Positive Cancer.Multiple mechanisms of extracellular tau spreading in a non-transgenic tauopathy model.Non-Covalent Loading of Anti-Cancer Doxorubicin by Modularizable Peptide Self-Assemblies for a Nanoscale Drug Carrier.The nuclear localization signal sequence of porcine circovirus type 2 ORF2 enhances intracellular delivery of plasmid DNA.A Functional MicroRNA Screening Method for Organ Morphogenesis.

P2860

Q33581506-5DDAB492-7E02-4B8D-90D7-14C3F145B08F Q33904910-AF5D52E1-2857-4836-9301-9CFAB549A505 Q35169140-15775B05-D69B-4E3B-B84B-C0A88AF8F5F8 Q35647187-F1D911F7-3411-4173-812F-E6BF9372210E Q35783096-E29B8F0F-2AC0-446C-9AA7-D355DDF5B0F9 Q35967737-895A2AF9-096E-43BC-9895-B9572A16FA3E Q37347451-2FAED0AF-E62B-4C74-B259-BECD64D0213A Q37529859-AEDB9825-234A-47F7-9E18-233B48424813 Q37677077-9CCE8226-E485-42F3-A672-A96C454180A5 Q37872613-72E109C6-FFB4-4238-BC5A-491D5151EA7B Q38269128-38998CAA-424A-43D6-A4E3-D112268DFB69 Q38391282-17916348-6C2B-4D16-833B-543E347085DC Q38747732-52784493-669A-4B33-A212-F3BB913D3389 Q38974213-BFE59610-0842-4375-9560-A054CBCE319A Q38974236-0142AB5E-5BE1-4726-896A-5EAEAEAA2C31 Q40472266-99DB1121-2E76-4F1D-939B-AD4E448BE7A0 Q40589508-268D1E4D-9ADA-4645-9A3C-EF07DE21F8CF Q41549396-E5584E70-CF96-4113-AB83-B5D3B7D3EDFC Q41786247-0BF53673-BD55-4E10-9D11-F6204C21AC63 Q42070603-BD1360DB-C88A-456B-BE91-CA6EA313E85A Q43103264-5AFF4D97-05B7-459A-B113-FFCD0BBB453E Q50120083-90D80194-2B4F-4C4A-A0AC-F2A804E687F6 Q50527092-99B39E5B-DBEF-46B4-A47A-CC02CCB5E81F Q52784405-77762A6F-9C54-4769-BF22-76FEB957FEB6

P2860

Recent Developments in Peptide-Based Nucleic Acid Delivery

http://www.wikidata.org/entity/Q27487857

description

2008 nî lūn-bûn

@nan

2008 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Recent Developments in Peptide-Based Nucleic Acid Delivery

@ast

Recent Developments in Peptide-Based Nucleic Acid Delivery

@en

Recent Developments in Peptide-Based Nucleic Acid Delivery

@nl

type

label

Recent Developments in Peptide-Based Nucleic Acid Delivery

@ast

Recent Developments in Peptide-Based Nucleic Acid Delivery

@en

Recent Developments in Peptide-Based Nucleic Acid Delivery

@nl

prefLabel

Recent Developments in Peptide-Based Nucleic Acid Delivery

@ast

Recent Developments in Peptide-Based Nucleic Acid Delivery

@en

Recent Developments in Peptide-Based Nucleic Acid Delivery

@nl

P1433

Q27487857-F5791AD9-9774-4EF6-A1BF-DC170C4D4819

P1476

Q27487857-D404356E-06EC-4796-A7F0-B8D71918530B

P2093

Q27487857-63C832BB-D144-4FAE-9C39-9A82D6D593E2

Q27487857-B02CD48F-82FB-48BC-8C09-EEDE7A5EA7DC

Q27487857-C2C23BDD-9450-47D3-A363-F93B8339EDA8

P2860

Q27487857-01A08861-51C9-4EE6-8F6B-B02EA01C91AA

Q27487857-02052E6A-0F88-42AB-B660-4B9266358E16

Q27487857-04DC7A3A-040A-4526-94F8-4FBE1DD67F13

Q27487857-062DF269-5F67-47E9-BDC9-6787D9E4FAD4

Q27487857-072C4762-8202-430E-B141-8A4762E746A6

Q27487857-07E2314B-A924-4F3A-BB75-D82BFCFF6DBE

Q27487857-095502A4-E713-4A75-97C9-CE5089A8DFCA

Q27487857-0B14ECC0-8651-4CA5-A902-8FE0AB4EF3CA

Q27487857-0D83631E-2AE2-45E7-ACAE-05149A0C1D16

Q27487857-0DC35FA1-3A24-49AA-B373-92ED42781BD0

P304

Q27487857-1BDCD0EB-FCA5-4F97-95A8-F1B449C16316

P31

Q27487857-3D80E36E-2EB4-4F94-912D-C3550C931280

P3181

Q27487857-23B32826-BAB0-40E4-B2C6-D64633BE0F1E

P356

Q27487857-71A2D209-404E-4FEE-9B98-FAF199F997E4

P407

Q27487857-DFC0F95A-001D-4257-B157-4913AECE2DB7

P433

Q27487857-D11324CE-A8A5-4BEB-B0EE-1D97C5923515

P478

Q27487857-FB0BE95D-2B39-4E82-8D0B-A6DC37C3D8C9

P577

Q27487857-4B3BB4D9-ADDA-4CD8-A5C9-87DB1779FA88

P5875

Q27487857-BDA0C237-DF91-43AB-8D91-A980AEB14591

P698

Q27487857-984015BB-BC35-4805-B0C9-CD02A7ECDBF7

P921

Q27487857-1543E20C-D688-40D9-9007-95B0C0712DF8

Q27487857-5B9C26F5-45CF-4E64-87A7-5433AD2C61BE

P932

Q27487857-86F2E2E7-92B5-4CBA-A01C-5452F7133C27

P3181

P356

P1433

International Journal of Molecular Sciences

P1476

Recent Developments in Peptide-Based Nucleic Acid Delivery

@en

P2093

Sandra D Laufer

http://www.w3.org/2001/XMLSchema#string

Sandra Veldhoen

http://www.w3.org/2001/XMLSchema#string

Tobias Restle

http://www.w3.org/2001/XMLSchema#string

P2860

Inhibition of dengue virus serotypes 1 to 4 in vero cell cultures with morpholino oligomers

External control of Her2 expression and cancer cell growth by targeting a Ras-linked coactivator

Antisense morpholino-oligomers directed against the 5' end of the genome inhibit coronavirus proliferation and growth

miR-122 targeting with LNA/2'-O-methyl oligonucleotide mixmers, peptide nucleic acids (PNA), and PNA-peptide conjugates

In vitro resistance selection and in vivo efficacy of morpholino oligomers against West Nile virus

Synthesis, cellular uptake and HIV-1 Tat-dependent trans-activation inhibition activity of oligonucleotide analogues disulphide-conjugated to cell-penetrating peptides

Modified branched peptides with a histidine-rich tail enhance in vitro gene transfection

A versatile reducible polycation-based system for efficient delivery of a broad range of nucleic acids

Cell-penetrating peptide conjugates of peptide nucleic acids (PNA) as inhibitors of HIV-1 Tat-dependent trans-activation in cells

Anti-HIV-1 activity of anti-TAR polyamide nucleic acid conjugated with various membrane transducing peptides.

P304

1276-320

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1494761

http://www.w3.org/2001/XMLSchema#string

P356

10.3390/IJMS9071276

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24238396

http://www.w3.org/2001/XMLSchema#string

P698

19325804

http://www.w3.org/2001/XMLSchema#string

P921

Aagianik kimischri

P932

2635728

http://www.w3.org/2001/XMLSchema#string